|
1
|
Song J and Li Y: miR-25-3p reverses
epithelial-mesenchymal transition via targeting Sema4C in
cisplatin-resistance cervical cancer cells. Cancer Sci. 108:13–31.
2016.
|
|
2
|
Yi Y, Li H, Lv Q, Wu K and Zhang W, Zhang
J, Zhu D, Liu Q and Zhang W: miR-202 inhibits the progression of
human cervical cancer through inhibition of cyclin D1. Oncotarget.
7:72067–72075. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Azizmohammadi S, Safari A, Azizmohammadi
S, Kaghazian M, Sadrkhanlo M, Yahaghi E, Farshgar R and
Seifoleslami M: Molecular identification of miR-145 and miR-9
expression level as prognostic biomarkers for early-stage cervical
cancer detection. QJM. 110:11–15. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Chandrasekaran KS, Sathyanarayanan A and
Karunagaran D: Downregulation of HMGB1 by miR-34a is sufficient to
suppress proliferation, migration and invasion of human cervical
and colorectal cancer cells. Tumour Biol. 37:13155–13166. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Cong J, Liu R, Wang X, Jiang H and Zhang
Y: MiR-634 decreases cell proliferation and induces apoptosis by
targeting mTOR signaling pathway in cervical cancer cells. Artif
Cells Nanomed Biotechnol. 44:1694–1701. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Deng Y, Xiong Y and Liu Y: miR-376c
inhibits cervical cancer cell proliferation and invasion by
targeting BMI1. Int J Exp Pathol. 97:257–265. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Fan Z, Cui H, Yu H, Ji Q, Kang L, Han B,
Wang J, Dong Q, Li Y, Yan Z, et al: MiR-125a promotes paclitaxel
sensitivity in cervical cancer through altering STAT3 expression.
Oncogenesis. 5:e2232016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Fang W, Shu S, Yongmei L, Endong Z, Lirong
Y and Bei S: miR-224-3p inhibits autophagy in cervical cancer cells
by targeting FIP200. Sci Rep. 6:332292016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Huang P, Xi J and Liu S: MiR-139-3p
induces cell apoptosis and inhibits metastasis of cervical cancer
by targeting NOB1. Biomed Pharmacother. 83:850–856. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Xia D, Li X, Niu Q, Liu X, Xu W, Ma C, Gu
H, Liu Z, Shi L, Tian X, et al: MicroRNA-185 suppresses pancreatic
cell proliferation by targeting transcriptional coactivator with
PDZ-binding motif in pancreatic cancer. Exp Ther Med. 15:657–666.
2018.PubMed/NCBI
|
|
11
|
Zhu X, Ju S, Yuan F, Chen G, Shu Y, Li C,
Xu Y, Luo J and Xia L: microRNA-664 enhances proliferation,
migration and invasion of lung cancer cells. Exp Ther Med.
13:3555–3562. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Cheng X, Chen J and Huang Z: miR-372
promotes breast cancer cell proliferation by directly targeting
LATS2. Exp Ther Med. 15:2812–2817. 2018.PubMed/NCBI
|
|
13
|
Zheng F, Zhang J, Luo S, Yi J, Wang P,
Zheng Q and Wen Y: miR-143 is associated with proliferation and
apoptosis involving ERK5 in HeLa cells. Oncol Lett. 12:3021–3027.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Azam AT, Bahador R, Hesarikia H, Shakeri M
and Yeganeh A: Downregulation of microRNA-217 and microRNA-646 acts
as potential predictor biomarkers in progression, metastasis, and
unfavorable prognosis of human osteosarcoma. Tumour Biol.
37:5769–5773. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Popov A, Szabo A and Mandys V: Small
nucleolar RNA U91 is a new internal control for accurate microRNAs
quantification in pancreatic cancer. BMC Cancer. 15:7742015.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhou L, Xu Z, Ren X, Chen K and Xin S:
MicroRNA-124 (MiR-124) inhibits cell proliferation, metastasis and
invasion in colorectal cancer by downregulating Rho-associated
protein kinase 1 (ROCK1). Cell Physiol Biochem. 38:1785–1795. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Xu B, Huang Y, Niu X, Tao T, Jiang L, Tong
N, Chen S, Liu N, Zhu W and Chen M: Hsa-miR-146a-5p modulates
androgen-independent prostate cancer cells apoptosis by targeting
ROCK1. Prostate. 75:1896–1903. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Hu CB, Li QL, Hu JF, Zhang Q, Xie JP and
Deng L: miR-124 inhibits growth and invasion of gastric cancer by
targeting ROCK1. Asian Pac J Cancer Prev. 15:6543–6546. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Li J, Song Y, Wang Y, Luo J and Yu W:
MicroRNA-148a suppresses epithelial-to-mesenchymal transition by
targeting ROCK1 in non-small cell lung cancer cells. Mol Cell
Biochem. 380:277–282. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Shin JY, Kim YI, Cho SJ, Lee MK, Kook MC,
Lee JH, Lee SS, Ashktorab H, Smoot DT, Ryu KW, et al: MicroRNA 135a
suppresses lymph node metastasis through down-regulation of ROCK1
in early gastric cancer. PLoS One. 9:e852052014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wan X, Cheng Q, Peng R, Ma Z, Chen Z, Cao
Y and Jiang B: ROCK1, a novel target of miR-145, promotes glioma
cell invasion. Mol Med Rep. 9:1877–1882. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Hwang HW and Mendell JT: MicroRNAs in cell
proliferation, cell death, and tumorigenesis. Br J Cancer. 96
Suppl:S40–S44. 2007.
|
|
24
|
Gandellini P, Giovannetti E and Nicassio
F: MicroRNAs in cancer management: Big challenges for small
molecules. Biomed Res Int. 2015:9821562015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Li GB, Cheng Q, Liu L, Zhou T, Shan CY, Hu
XY, Zhou J, Liu EH, Li P and Gao N: Mitochondrial translocation of
cofilin is required for allyl isothiocyanate-mediated cell death
via ROCK1/PTEN/PI3K signaling pathway. Cell Commun Signal.
11:502013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Narumiya S, Tanji M and Ishizaki T: Rho
signaling, ROCK and mDia1, in transformation, metastasis and
invasion. Cancer Metastasis Rev. 28:65–76. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Matsubara M and Bissell MJ: Inhibitors of
Rho kinase (ROCK) signaling revert the malignant phenotype of
breast cancer cells in 3D context. Oncotarget. 7:31602–31622. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Liu S: The ROCK signaling and breast
cancer metastasis. Mol Biol Rep. 38:1363–1366. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Xu X, Li S, Lin Y, Chen H, Hu Z, Mao Y, Xu
X, Wu J, Zhu Y, Zheng X, et al: MicroRNA-124-3p inhibits cell
migration and invasion in bladder cancer cells by targeting ROCK1.
J Transl Med. 11:2762013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Schmidt LJ, Duncan K, Yadav N, Regan KM,
Verone AR, Lohse CM, Pop EA, Attwood K, Wilding G, Mohler JL, et
al: RhoA as a mediator of clinically relevant androgen action in
prostate cancer cells. Mol Endocrinol. 26:716–735. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Reymond N, Im JH, Garg R, Cox S, Soyer M,
Riou P, Colomba A, Muschel RJ and Ridley AJ: RhoC and ROCKs
regulate cancer cell interactions with endothelial cells. Mol
Oncol. 9:1043–1055. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Karius T, Schnekenburger M, Dicato M and
Diederich M: MicroRNAs in cancer management and their modulation by
dietary agents. Biochem Pharmacol. 83:1591–1601. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Kong YW, Ferland-McCollough D, Jackson TJ
and Bushell M: microRNAs in cancer management. Lancet Oncol.
13:e249–e258. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Lowery AJ, Miller N, McNeill RE and Kerin
MJ: MicroRNAs as prognostic indicators and therapeutic targets:
Potential effect on breast cancer management. Clin Cancer Res.
14:360–365. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Tufman A, Tian F and Huber RM: Can
microRNAs improve the management of lung cancer patients? A
clinician's perspective. Theranostics. 3:953–963. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Liang LH and He XH: Macro-management of
microRNAs in cell cycle progression of tumor cells and its
implications in anti-cancer therapy. Acta Pharmacol Sin.
32:1311–1320. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Chen R, Cheng Y, Zhang Y, Li Z and Geng L:
RhoC mediates invasion and migration of CaSki cells through the
Rho-associated serine-threonine protein kinase 1 signaling pathway.
Int J Gynecol Cancer. 24:184–191. 2014. View Article : Google Scholar : PubMed/NCBI
|
